🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the safety and efficacy of exogeno...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2018-12-05
Trial ID
NCT03769116
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440
A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV In...
Status
Completed
Location
Nucleus Network Limited
Start Date
2017-12-08
Trial ID
NCT03384290
Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01297062
Treatments Being Tested
The purpose of this protocol is to evaluate the efficacy of tulisokibart in...
Status
Active Not Recruiting
Location
Digestive Health Specialists ( Site 0135)
Start Date
2023-10-25
Trial ID
NCT06052059
Treatments Being Tested
The primary objective of this study is to assess the safety and outcomes of...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-06-01
Trial ID
NCT02292784
The goals of this clinical study are to first learn more about safety and d...
Status
Recruiting
Location
Investigative Site
Start Date
2025-07-31
Trial ID
NCT07096193
Treatments Being Tested
This is a phase 1/2a double-blinded, placebo-controlled, dose-escalating st...
Status
Recruiting
Location
Liverpool Hospital
Start Date
2024-03-04
Trial ID
NCT06138743
Treatments Being Tested